Introduction
The biosynthetic conversion of dihydroneopterin triphosphate (NH2P3) to tetrahydrobiopterin (BH4) is still unclear in its details. While earlier ~)rOPOSals favoured the involvement of sepiapterin as an intermediate (1, 2, 3) , more recent work from several laboratories suggests that this is not the case, and that biosynthesis proceeds via tetrahydropterin interme diates (4) (5) (6) (7) (8) . The conversion of NH2P3 to BH4 requires reduction with 4 electrons or 2 hydride equivalents (9) ; the latter are likely to originate from reduced pyridine nucleotides (7) . Earlier studies from Krivi and Brown (10) dealt with the incorporation of label from (4S-3 H)NADPH into sepiapterin. As also discussed elsewhere (9) , the lack of stereospecifici ty in the incorporation of label into sepiapterin, and the probable nonin volvement of the latter in the biosynthesis (4) (5) (6) (7) (8) , question the relevance of these (10) results. 144 Studies on the origin of the hydrogens at the C(2'), and C(3') positions of the side chain of BH4, and on the mode of transfer of the reducing equivalents from NAD(P)H might help elucidate the mechanism of biosynthesis, and in particular might provide information on the intermediate occurrence and structure of tetrahydropterins. In this report we summarize results of experiments involving the use of specifically labelled (4R-or S_2H)NAD(P)H in the biosynthesis of BH4 in normal as well as in deuterated solvent. The details of these studies will be published elsewhere (8) .
Results
The analysis of the incorporation experiments was carried out by gas chromatography-mass spectrometry by recording the molecular ion of BH4 and Sepiapterin reductase catalyzes the reduction of either sepiapterin to BH2 or di hydrosepi apteri n (6-1 actoyl-tetrahydropteri n) to BH4' We found tha during these reactions, the 4-pro-S hydrogen of NADPH was transferred specifically to the C(l') position of the substrates.
The results of the studies involving the use of partially purified human liver extracts, starting with NH2P3 as a substrate, are summarized in (-) not measured (a-c) Exchange of label in NADPH was determined at the end of the incubation as a control A striking result was obtained when the incubation was carried out in 2HZO using unlabelled-NADPH (Table 1) ; under these conditions approx. equivalents of label were incorporated into BH4, and most probably one each at the positions C(6), C(1'), C(2'), and C(3'). In accordance with this, no 1abe 1 was i ncorpora ted when the experi ments were conduc ted in H20 us i ng ~ither (4R-or 4S-2 H)NAD(P)H (Table 1 ). This unexpected result was due to a relatively rapid exchange of the label in the pyridine nucleotide, which was catalyzed most probably by a diaphorase activity in the extracts. In fact, upon addition of the diaphorase inhibitor, arse;lite (12), the exchange was inhibited considerab-Iy, although it could not be suppressed completely (Table 1) . Thus in the presence of NaAsOZ, approx. 2 equivalents of 1abel from (4S-Z H) NADPH were incorporated into BHZ.
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This, and the analysis of the MS-fragments clearly indicate that the 4-pro-S hydrogen of NADPH was transferred to BH4, and that one label was introduced into the position C(1'), and one into C(2'). In the complementary experiment carried out in 2H20 using unlabelled NADPH, approx. one equivalent of label was found in BHZ, most probably at the position C(3'), and two equivalents in BH4 at the positions C(6) and C(3').
The incubation of human liver extracts with sepiapterin and (4S-2 H)NADPH in 2H20 resulted in the incorporation of label into BH2' However, under the same conditions using labelled NADH, no label was transferred. This indicates that the exchange of the 4-hydrogens with solvent is much faster with NADH, as compared to NADPH under our experimental conditions.
Discussion
Dihydrofolate reductase was shown to catalyze the transfer of the 4R-label of NADPH to the position C(6) of BH2 to yield 6(R)BH4. Since there was no transfer of label to this position during the formation of BH4 from NH2P3 by human 1iver extracts, this appears to rule out dihydrofolate reductase as an enzyme involved in the conversion of NH2P3 to BH4. This is in agreement with the conclusions of others (13) . The finding of incorporation of solvent hydrogen into position C(6) of BH4 is of obvious significance.
Clearly the N(5)-C(6) double bond is not being reduced directly by NAD(P)H. An alternate pathway for the generation of a 5,6-dihydro function has been put forward by our groups (7, 9) , as well as by others (4-6) and involves an internal transfer of a formal hydride from C(1' l-H to the N(5)-C(6) double bond. This mechanism is similar to the well known internal redox reactions observed in amino-sugar chemistry, which is thermodynamically feasible (9) and has counterparts in some pterin model reactions studied by Pfleiderer (15) .
The state of the art knowledge on the mechanisms of biosynthesis of BH4 from ~JH2P3 can be summari zed by the sequences of Scheme 1. In this scheme an active center base might initiate catalysis by attacking C(Z')-H, and thus promoting elimination of triphosphate (step A). In fact, triphosphate has recently been shown to be eliminated from NH2P3 when the latter is incubated with purified "phosphate-eliminating enzyme" from human liver (16) . The proton abstracted by this base can be redonated (partially)
to the enolic double bond at C(2')-C(3') and thus incorporated into the final product, BH4. The base involved could partially exchange with solvent, or it might be a bi-or trifunctional one which does not exchange.
This in turn would explain the partial incorporation of label from the solvent into position C(3') of BH4 (8) . It is conceivable that the same base also functions in the abstraction of a proton at C(l')-H (Scheme 1, step B), thus initiating the transfer of electrons to the pterin nucleus.
In accordance with this, the same fraction of phosphate-eliminating enzyme from human liver, which catalyzes the elimination of -OP3 from NH2P3, also catalyzes the formation of the tetrahydropterin chromophore, i.e. its conversion to a 5,6-dihydro,C(l')-keto-pterin (17) . It should be pointed out that the presence of a second enzyme in the fraction catalyzing this event cannot yet be excl uded, however, it appears that processes A and Bare early events in the NH2P3 conversion to BH4 (17) . On the other hand, the sequence of steps A and B (Scheme 1) could be reversed without altering the general conclusions. The di rect reducti on of the di keto-tetrahydropteri n by NADPH woul d then terminate the sequence (Scheme 1, step C) and ensue in BH4. It has been shown that sepiapterin reductase can catalyze the oxidoreduction at both the C( 1 r), and the C(2') functions of biopterins (17) . This suggests that its function might indeed consist in these last two reductions steps, the involvement of a different enzyme, however, cannot be excluded at present.
